Laboratory Analysis of the Antibody-based COVID-19 Therapy That GSK is Developing with ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Laboratory analysis of the antibody-based COVID-19 therapy that GSK is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)